July 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX ...
Cardiac Resynchronization Therapy Devices (CRT)
Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.
July 21, 2017
July 13, 2017 — Experts in heart failure management gathered in June to discuss varying scientific evidence in their ...
July 13, 2017
July 6, 2017 — New data showed use of Medtronic’s cardiac resynchronization therapy (CRT) devices with its proprietary ...
July 06, 2017
July 3, 2017 — Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation ...
July 03, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for ...
June 29, 2017
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...
June 22, 2017
June 20 2017 — Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the ...
June 20, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 2017 H ...
May 26, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancements ...
May 25, 2017
This video, provided by ERB, demonstrates the function and implantation of the WiSE CRT (Wireless Stimulation ...
May 23, 2017
May 15, 2017 – The U.S. Food and Drug Administration (FDA) has granted market clearance Medtronic’s portfolio of ...
May 15, 2017
May 11, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of the company's MultiPole Pacing ...
May 11, 2017
May 10, 2017 — Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardi ...
May 10, 2017
May 9, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and the launch of Sentus ProMRI, the ...
May 09, 2017
May 9, 2017 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific’s Resonate family of implantable ...
May 09, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now